494 A phase I trial of SCH900776, a selective inhibitor of checkpoint kinase CHK-1, in combination with Gemcitabine in advanced solid tumors

Autor:	J. Strosberg, G. Kato, David S. Mendelson, J. Goldman, J. Horowitz, Lee S. Rosen, G. Springett, C. Soon, Pamela N. Munster, Adil Daud
Rok vydání:	2010
Předmět:	Cancer Research Oncology Chemistry Kinase Phase (matter) Cancer research medicine Gemcitabine medicine.drug
Zdroj:	European Journal of Cancer Supplements. 8:158
ISSN:	1359-6349
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4c4e55e8cfe8a37680b3c79c0f12884b https://doi.org/10.1016/s1359-6349(10)72201-1 Zobrazit plný text záznamu Full Text from ScienceDirect